Literature DB >> 22821732

Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cells.

Nevila Hyka-Nouspikel1, Joëlle Desmarais, Paul J Gokhale, Mark Jones, Mark Meuth, Peter W Andrews, Thierry Nouspikel.   

Abstract

Human embryonic stem cells (hESCs) tend to lose genomic integrity during long periods of culture in vitro and to acquire a cancer-like phenotype. In this study, we aim at understanding the contribution of point mutations to the adaptation process and at providing a mechanistic explanation for their accumulation. We observed that, due to the absence of p21/Waf1/Cip1, cultured hESCs lack proper cell cycle checkpoints and are vulnerable to the kind of DNA damage usually repaired by the highly versatile nucleotide excision repair (NER) pathway. In response to UV-induced DNA damage, the majority of hESCs succumb to apoptosis; however, a subpopulation continues to proliferate, carrying damaged DNA and accumulating point mutations with a typical UV-induced signature. The UV-resistant cells retain their proliferative capacity and potential for pluripotent differentiation and are markedly less apoptotic to subsequent UV exposure. These findings demonstrate that, due to deficient DNA damage response, the modest NER activity in hESCs is insufficient to prevent increased mutagenesis. This provides for the appearance of genetically aberrant hESCs, paving the way for further major genetic changes.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Year:  2012        PMID: 22821732     DOI: 10.1002/stem.1177

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  26 in total

1.  Pluripotent and somatic stem cells: from basic science to utilization in disease modeling and therapeutic application. Meeting report on the 7th International Meeting of the Stem Cell Network North Rhine Westphalia.

Authors:  Stefan Radtke; Peter A Horn
Journal:  Cell Reprogram       Date:  2013-09-10       Impact factor: 1.987

2.  Development of a Monitoring Method for Nonlabeled Human Pluripotent Stem Cell Growth by Time-Lapse Image Analysis.

Authors:  Mika Suga; Hiroaki Kii; Keiichi Niikura; Yasujiro Kiyota; Miho K Furue
Journal:  Stem Cells Transl Med       Date:  2015-05-13       Impact factor: 6.940

Review 3.  Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Authors:  So Gun Hong; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

4.  Mutation frequency dynamics in HPRT locus in culture-adapted human embryonic stem cells and induced pluripotent stem cells correspond to their differentiated counterparts.

Authors:  Miriama Krutá; Monika Šeneklová; Jan Raška; Anton Salykin; Lenka Zerzánková; Martin Pešl; Eva Bártová; Michal Franek; Aneta Baumeisterová; Stanislava Košková; Kai J Neelsen; Aleš Hampl; Petr Dvořák; Vladimír Rotrekl
Journal:  Stem Cells Dev       Date:  2014-07-25       Impact factor: 3.272

Review 5.  Developmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation.

Authors:  Kevin G Chen; Barbara S Mallon; Kory R Johnson; Rebecca S Hamilton; Ronald D G McKay; Pamela G Robey
Journal:  Stem Cell Res       Date:  2014-02-19       Impact factor: 2.020

Review 6.  Stem cell application for osteoarthritis in the knee joint: A minireview.

Authors:  Kristin Uth; Dimitar Trifonov
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

7.  DNA damage responses in cancer stem cells: Implications for cancer therapeutic strategies.

Authors:  Qi-En Wang
Journal:  World J Biol Chem       Date:  2015-08-26

Review 8.  Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies.

Authors:  Andrew S Lee; Chad Tang; Mahendra S Rao; Irving L Weissman; Joseph C Wu
Journal:  Nat Med       Date:  2013-08-06       Impact factor: 53.440

Review 9.  Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies.

Authors:  James A Heslop; Thomas G Hammond; Ilaria Santeramo; Agnès Tort Piella; Isabel Hopp; Jing Zhou; Roua Baty; Enrique I Graziano; Bernabé Proto Marco; Alexis Caron; Patrik Sköld; Peter W Andrews; Melissa A Baxter; David C Hay; Junnat Hamdam; Michaela E Sharpe; Sara Patel; David R Jones; Jens Reinhardt; Erik H J Danen; Uri Ben-David; Glyn Stacey; Petter Björquist; Jacqueline Piner; John Mills; Cliff Rowe; Giovanni Pellegrini; Swaminathan Sethu; Daniel J Antoine; Michael J Cross; Patricia Murray; Dominic P Williams; Neil R Kitteringham; Chris E P Goldring; B Kevin Park
Journal:  Stem Cells Transl Med       Date:  2015-02-26       Impact factor: 6.940

Review 10.  Lessons learned about human stem cell responses to ionizing radiation exposures: a long road still ahead of us.

Authors:  Mykyta Sokolov; Ronald Neumann
Journal:  Int J Mol Sci       Date:  2013-07-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.